California Healthline November 18, 2022
Liz Szabo

Among the more remarkable legacies of the covid-19 pandemic is how quickly federal regulators, the health care industry, and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

But that fast-track focus is missing from another, less publicized epidemic: an explosion in sexually transmitted diseases that can cause chronic pain and infertility among infected adults and disable or kill infected newborns. The disparity has amplified calls from researchers, public health advocates, and health care companies urging the federal government to greenlight at-home testing kits that could vastly multiply the number of Americans testing for STDs.

Online shoppers can already choose from more than a dozen self-testing kits, typically ranging in price from $69 to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Home, Patient / Consumer, Provider, Public Health / COVID
FDA launches initiative to advance home healthcare models, devices
Novant Health launches 'hospital at home' with $2.7M donation
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site
BrightStar Care Dives Further Into Hospital-At-Home Care, Expands Partnership With Medically Home

Share This Article